Cambium Bio Limited has released a press release.
Appendix 4E and Annual Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Cambium Bio
- Regeneus to present at FNN Virtual Investor Event
- US Patent for Sygenus
- Regeneus and Kyocera sign Progenza OA deal
- Progenza OA Kyocera negotiations update
- Kyocera completes Progenza Due Diligence
Later from Cambium Bio
- Regeneus to be granted new Sygenus patent in Canada
- Regeneus receives $5.6M milestone payment from Kyocera
- CEO Appointment and Resignation
- Clarification on Quarterly Activity Report and Appendix 4C
- Appendix 4C - Quarterly Report
Follow Cambium Bio into a list and get an email when it puts out news.
Follow Cambium Bio